---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-137079"
form_type: "8-K"
ticker: "MRNA"
cik: "0001682852"
company_name: "Moderna, Inc."
filed_at: "2023-05-05T23:59:59+00:00"
generated_at: "2026-06-15T16:59:43.845862+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Moderna Stockholders Elect Three Class II Directors and Approve Executive Compensation at 2023 Annual Meeting

## Summary
- Elected Stephen Berenson (226.6M for, 64.2M withheld), Sandra Horning (281.8M for, 8.9M withheld), and Paul Sagan (219.0M for, 71.7M withheld) as Class II directors.
- Advisory vote on named executive officer compensation approved with 254.1M for, 34.9M against, and 1.6M abstentions.
- Ratification of Ernst & Young as independent auditor for 2023 approved with 352.0M for, 3.9M against, and 0.2M abstentions.
- Shareholder proposal requesting report on feasibility of transferring intellectual property defeated: 21.4M for, 268.0M against, 1.3M abstain.

## SEC filing metadata
- accession: 0001193125-23-137079
- form_type: 8-K
- ticker: MRNA
- cik: 0001682852
- company_name: Moderna, Inc.
- filed_at: 2023-05-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682852/000119312523137079/0001193125-23-137079-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682852/000119312523137079/d415922d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-137079
- JSON: https://secwatch.observer/filing/0001193125-23-137079.json
- Plain text: https://secwatch.observer/filing/0001193125-23-137079.txt

## Key facts
- Shareholder Votes
  Moderna, Inc. shareholders approved Ratification of appointment of independent registered public accounting firm at the 2023-05-03 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-05-03
  source text: Proposal 3. Ratification of appointment of independent registered public accounting firm. The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023, with the votes cast as follows:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682852/000119312523137079/0001193125-23-137079-index.htm
- Shareholder Votes
  Moderna, Inc. shareholders approved Approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers at the 2023-05-03 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-05-03
  source text: Proposal 2. Approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers. The Company’s stockholders approved, on an advisory basis, the compensation of the named executive officers.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682852/000119312523137079/0001193125-23-137079-index.htm
- Shareholder Votes
  Moderna, Inc. shareholders rejected Shareholder proposal requesting a report on feasibility of transferring intellectual property at the 2023-05-03 meeting.
  - Outcome: failed
  - Meeting: 2023-05-03
  source text: Proposal 4. Shareholder proposal requesting a report on feasibility of transferring intellectual property.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682852/000119312523137079/0001193125-23-137079-index.htm
- Shareholder Votes
  Moderna, Inc. shareholders approved Election of Class II directors at the 2023-05-03 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-05-03
  source text: Proposal 1. Election of directors. By the vote reflected below, the Company’s stockholders elected each of the following individuals to serve as Class II directors for a three-year term expiring at the Company’s 2026 Annual Meeting of Stockholders and until his or her respective successor is duly elected and qualified, or such director’s earlier death, resignation or removal:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682852/000119312523137079/0001193125-23-137079-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.